Remyelination in multiple sclerosis from the miRNA perspective
- PMID: 37333618
- PMCID: PMC10270307
- DOI: 10.3389/fnmol.2023.1199313
Remyelination in multiple sclerosis from the miRNA perspective
Abstract
Remyelination relies on the repair of damaged myelin sheaths, involving microglia cells, oligodendrocyte precursor cells (OPCs), and mature oligodendrocytes. This process drives the pathophysiology of autoimmune chronic disease of the central nervous system (CNS), multiple sclerosis (MS), leading to nerve cell damage and progressive neurodegeneration. Stimulating the reconstruction of damaged myelin sheaths is one of the goals in terms of delaying the progression of MS symptoms and preventing neuronal damage. Short, noncoding RNA molecules, microRNAs (miRNAs), responsible for regulating gene expression, are believed to play a crucial role in the remyelination process. For example, studies showed that miR-223 promotes efficient activation and phagocytosis of myelin debris by microglia, which is necessary for the initiation of remyelination. Meanwhile, miR-124 promotes the return of activated microglia to the quiescent state, while miR-204 and miR-219 promote the differentiation of mature oligodendrocytes. Furthermore, miR-138, miR-145, and miR-338 have been shown to be involved in the synthesis and assembly of myelin proteins. Various delivery systems, including extracellular vesicles, hold promise as an efficient and non-invasive way for providing miRNAs to stimulate remyelination. This article summarizes the biology of remyelination as well as current challenges and strategies for miRNA molecules in potential diagnostic and therapeutic applications.
Keywords: demyelination; miRNA; microRNA; multiple sclerosis; myelin; oligodendrocyte; oligodendrocyte precursor cells; remyelination.
Copyright © 2023 Maciak, Dziedzic and Saluk.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis.Neurobiol Dis. 2019 May;125:154-162. doi: 10.1016/j.nbd.2019.01.019. Epub 2019 Jan 29. Neurobiol Dis. 2019. PMID: 30707940
-
MicroRNAs in oligodendrocyte development and remyelination.J Neurochem. 2022 Aug;162(4):310-321. doi: 10.1111/jnc.15618. Epub 2022 May 10. J Neurochem. 2022. PMID: 35536759 Review.
-
Donepezil, a drug for Alzheimer's disease, promotes oligodendrocyte generation and remyelination.Acta Pharmacol Sin. 2019 Nov;40(11):1386-1393. doi: 10.1038/s41401-018-0206-4. Epub 2019 Mar 27. Acta Pharmacol Sin. 2019. PMID: 30918344 Free PMC article.
-
Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.J Neurosci. 2015 Sep 2;35(35):12162-71. doi: 10.1523/JNEUROSCI.2127-15.2015. J Neurosci. 2015. PMID: 26338327 Free PMC article.
-
The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.Adv Exp Med Biol. 1999;468:183-97. doi: 10.1007/978-1-4615-4685-6_15. Adv Exp Med Biol. 1999. PMID: 10635029 Review.
Cited by
-
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis.Int J Mol Sci. 2024 Sep 4;25(17):9588. doi: 10.3390/ijms25179588. Int J Mol Sci. 2024. PMID: 39273535 Free PMC article. Review.
-
Demyelination and Remyelination: General Principles.Adv Neurobiol. 2025;43:207-255. doi: 10.1007/978-3-031-87919-7_9. Adv Neurobiol. 2025. PMID: 40500500 Review.
-
Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus - focus on juvenile-onset systemic lupus erythematosus.Curr Opin Rheumatol. 2025 Mar 1;37(2):149-163. doi: 10.1097/BOR.0000000000001072. Epub 2024 Dec 11. Curr Opin Rheumatol. 2025. PMID: 39660463 Free PMC article. Review.
-
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of Progress.Biomedicines. 2025 Feb 4;13(2):357. doi: 10.3390/biomedicines13020357. Biomedicines. 2025. PMID: 40002770 Free PMC article. Review.
-
Primary Progressive Multiple Sclerosis: New Therapeutic Approaches.Neuropsychopharmacol Rep. 2025 Sep;45(3):e70039. doi: 10.1002/npr2.70039. Neuropsychopharmacol Rep. 2025. PMID: 40653594 Free PMC article. Review.
References
-
- Arranz L., De Castro N. M., Baeza I., Maté I., Viveros M. P., De la Fuente M. (2010). Environmental enrichment improves age-related immune system impairment: long-term exposure since adulthood increases life span in mice. Rejuvenation Res. 13, 415–428. doi: 10.1089/rej.2009.0989, PMID: - DOI - PubMed
-
- Atlas of MS 2020 – Epidemiology Report (2020). MS International Federation. Available at: https://www.msif.org/resource/atlas-of-ms-2020/ (accessed March 28, 2023).
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources